Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Why Is Horizon Therapeutics (HZNP) Up 38.3% Since Last Earnings Report?
12:48pm, Friday, 02'nd Dec 2022
Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock?
Horizon Therapeutics in early takeover talks
12:15pm, Thursday, 01'st Dec 2022
Shares of Horizon Therapeutics surged after the biotech firm, which specializes in autoimmune diseases, confirmed that it was in preliminary discussions with three large drug makers about a possible s
Horizon (HZNP) Up on Initial Talks of Buyout by Pharma Giants
01:33pm, Wednesday, 30'th Nov 2022
Horizon (HZNP) holds preliminary discussions with Amgen, Sanofi and Janssen, a subsidiary of J&J, seeking an offer for its acquisition by any one of the pharma giants. Shares rise.
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
10:54am, Wednesday, 30'th Nov 2022
Horizon Therapeutics (NASDAQ: HZNP ) stock is rising higher on Wednesday following reports that the company is considering a buyout. According to a news release from the company, it has engaged in ear
Horizon Therapeutics in preliminary sale talks with Amgen, Sanofi, J&J
10:37am, Wednesday, 30'th Nov 2022
CNBC's Jim Cramer and the 'Squawk on the Street' team discuss a new report that Horizon Therapeutics is in preliminary talks with major pharmaceutical companies over a potential takeover.
Horizon Therapeutics Draws Big Pharma Interest
10:16am, Wednesday, 30'th Nov 2022
Shares of Horizon surged after the company announced it is in "highly preliminary" discussions with three big pharma companies about a potential takeover. In the article, I discuss a potential deal va
Horizon Therapeutics Reconsiders Several Big Buyout Bids
10:10am, Wednesday, 30'th Nov 2022
Horizon Therapeutics PLC (NASDAQ:HZNP) is surging this morning, last seen up 29.6% at $102.10, following news that the company is reconsidering possible bids from Amgen (AMGN), Sanofi (SASY), and John
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi
05:38pm, Tuesday, 29'th Nov 2022
Horizon said Tuesday it's considering potential offers from three Big Pharma stalwarts, sending HZNP stock soaring more than 30% after hours. The post Horizon Therapeutics Rockets As It Considers Pote
Pharma giants take interest in acquiring Horizon Therapeutics
04:45pm, Tuesday, 29'th Nov 2022
Drugmaker Horizon Therapeutics PLC is fielding takeover interest, according to people familiar with the matter, as large pharmaceutical companies compete for fast-growing medicines to fuel sales.
Horizon Therapeutics Fields Takeover Interest from Pharma Giants
04:21pm, Tuesday, 29'th Nov 2022
The drugmaker recently had a market value close to $18 billion as big pharmaceutical companies rely on acquisitions to expand sales.
New Research Partnership With Horizon Therapeutics Could Be the Next Revenue Catalyst for Xeris
08:01pm, Monday, 28'th Nov 2022
Technology-based biopharma company Xeris (US:XERS) is set to boost its revenue with an upfront cash payment from a research collaboration and option agreement that was secured with mid-cap pharma Hori
Hot Biotech Stocks Rise Into Leadership; Pass Buy Points Or Build Bases
02:10pm, Friday, 25'th Nov 2022
Top biotech stocks surge within the IBD 50. Some pass buy points while others build bases.
Horizon Therapeutics (HZNP) is a Top-Ranked Value Stock: Should You Buy?
11:17am, Wednesday, 23'rd Nov 2022
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Xeris Biopharma inks research collaboration and option agreement with Horizon Therapeutics
09:26am, Wednesday, 23'rd Nov 2022
Xeris Biopharma Holdings (NASDAQ:XERS) said it has entered into a research collaboration and option agreement with Horizon Therapeutics PLC. Under the terms of the agreement, Xeris will use its prop
Horizon's (HZNP) Q3 Earnings & Revenues Surpass Estimates
12:48pm, Thursday, 03'rd Nov 2022
Horizon's (HZNP) earnings and revenues beat estimates in the third quarter of 2022. The company raises net sales guidance for 2022.
